Elsevier launched a new integrated Clinical Solutions product by acquiring Wellsheet to enhance clinical decision-making with verified patient-specific guidance.
Jun 03, 2026
New YorkInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMedicalMachine Learning
Product Description
Elsevier announced the acquisition of Wellsheet, aiming to provide clinicians with a seamless integration of verifiable clinical evidence and patient data directly within Electronic Health Records (EHR). This collaboration will enable more efficient decision-making and improve workflow for healthcare providers.
Company Information
Company
Elsevier
Location
New York, New York, United States
About
Elsevier is a global leader in health information and data analytics. The company focuses on enhancing clinical decision-making through innovative solutions like ClinicalKey AI, a generative AI-powered clinical support tool designed to improve patient care and streamline healthcare workflows. They aim to transform the way healthcare providers access and utilize actionable insights, thereby increasing efficiency at the point of care.
Fundz sees it the moment Elsevier ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.